This is how Dr. Berstein manages SSc-ILD #ACR22 @rheumnow #CurbsideConsult

GWAS analysis of 2.5m people (120k with gout) showing identifies 1486 candidate causal genes for gout. Looking at urate handling as well as disease propagation (eg. IL1/6). Widespread GWAS allowing us to investigate these diseases differently. Dr. John Cush #ACR22 #Plenary

Immunosuppressants (eg. MTX, RTX, MMF) can reduce immunogenicity to vaccines. VACIMRA study showing no difference in disease activity (beyond 1 month) and damage when MTX initiation was delayed by 1 month for the PCV13 pneumococcal vaccine. Dr. John Cush ABST1960 #ACR22

Foot involvement in RA not included in disease activity scores. This abstract showed that patients w/ active foot involvement have higher scores anyway (driven by physician & patient global) but examining feet would have only changed management in 3.1%. Dr. John Cush ABST0265 #ACR22

Should You Repeat the ENA Panel? Dr. Kathryn Dao ( TheDaoIndex) discusses abstract 0725, presented at #ACR22 Convergence. Abstract 0725: Utility of Repeat Extractable Nuclear Antigen Antibody Testing- a Retrospective Audit bit.ly/3O9wYMe

Wanna catch up w/ #Rheumatoid #Arthritis presentations at #ACR22? Dr. John Cush faculty has selected their « best » one for you and discuss w/ John Kay: Tune in 🎤rheumnow.com/podcast/ra-top… 📹: rheumnow.com/video/ra-topic… Richard Conway Janet Pope Julian Segan David Liew & me

RA Topic Panel RheumNow faculty recap the best and most interesting data presented at #ACR22 in RA. Panelists: Drs. Conway ( Richard Conway ), Najm ( Aurelie Najm) , Liew ( David Liew) , Pope (Janet Pope) , Segan (Julian Segan) bit.ly/3V40Snc